Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Biomatics Capital Partners

Status
ACTIVE
Global HQ
Washington, United States
Countries of investment
  • USA
Investment stages
  • Series A
  • Series B
Industries
    About
    Biomatics Capital Partners invests in AI, data, and automation companies that transform enterprise workflows across logistics, manufacturing, and healthcare.
    Min check size
    $500K
    Max check size
    $10M
    Fund size
    NPS

    Investment Thesis

    They seek highgrowth biotech and life sciences companies with cuttingedge technologies. It provides capital and strategic support to accelerate development and commercialization.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Manager's Experience

    With extensive experience in venture capital, the fund manager has successfully executed over 40 deals across various sectors, including biotechnology, healthcare, and software. Active primarily in North America and Europe, their investment strategy is characterized by a thematic focus on innovative solutions and transformative technologies. The manager has achieved notable exits, highlighting their operator-first approach that emphasizes strong team dynamics and operational efficiencies. Their data-driven analysis ensures informed decision-making, positioning them as a strategic leader in early to growth-stage investments.

    Biomatics Capital Partners Contacts Information

    Primary contact

    Secondary contact

    Team

    Julie Sunderland

    Boris Nikolic

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp